<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"><!-- InstanceBegin template="/Templates/articles.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1" />
<!-- InstanceBeginEditable name="doctitle" -->
<title>Influenza Vaccine Effectiveness | CDC EID</title>
<!-- InstanceEndEditable -->
<!-- InstanceBeginEditable name="head" -->
<meta name="keywords" content="human influenza, vaccine effectiveness, military personnel, dispatch" />
<meta name="Volume" content="13" />
<meta name="Issue" content="04" />
<meta name="Month" content="03" />
<meta name="Day" content="19" />
<meta name="Year" content="2007" />
<script language = "javascript">
<!--
function validation(passForm) {


//validates a message was entered
						if(passForm.textarea.value ==""){
					        alert("Please enter a comment in the message area.");
									passForm.textarea.focus();
									return false;
									}
					
//validates e-mail address
						var mail = passForm.From.value
						if(mail ==""){
						      alert("You must enter your e-mail address");
									passForm.From.focus();
									return false;
									}
					 var invalidChars = "/:,;";
					 //checks for invalid characters
					 for(i=0; i<invalidChars.length;i++){
					      badChar= invalidChars.charAt(i);
								if(mail.indexOf(badChar,0)!= -1){
								     alert("Invalid characters (/:,;) in e-mail address");
										 return false;
								}
					}
					//checks that @character exists
					atPos = mail.indexOf("@", 1);
					if(atPos == -1){
					     alert("Character @ and at least one character before @ required");
							 return false;
					}
					//checks that there are not two @'s
					if(mail.indexOf("@", 0)!= -1){
					      charPos= mail.indexOf("@", 0);
								if(mail.indexOf("@", charPos+1)!=-1){
								     alert("Only one @ allowed in e-mail address");
										 return false;
								}
						}		
					//checks that a period exists after the @ symbol
					periodPos = mail.indexOf(".", atPos);
							 if(periodPos == -1){
							 			 alert("Period missing after @ in e-mail address");
										 return false;
							}
					//checks that there are at least two characters after the period
					if(periodPos + 3 > mail.length){
					      alert("At least two characters required after the period in e-mail address");
								return false;
					}
					//checks that there is at least one character between the @ and period
					if (periodPos - atPos ==1){
						 alert("At least one character required betweeen @ and period in e-mail address");
						 return false;
				  }
return true;

}			 
//-->
</script>
<!-- InstanceEndEditable -->
<script language="JavaScript" type="text/JavaScript">
<!--
function MM_openBrWindow(theURL,winName,features) { //v2.0
  window.open(theURL,winName,features);
}
//-->
</script>
<style type="text/css">
@import url(../../../css/global.css);
@import url(../../../css/standard.css);
@import url(../../../css/specific.css);
.style1 {	font-size: 0.9em;
	color: #666666;
}
</style>
</head>

<body>
<div id="frame"><!-- #BeginLibraryItem "/Library/gblheader.lbi" --><!-- Start CDC Header Navigation Bar -->	
	<div id="cdchdrnav">
		<ul>
			<li style="background-image: url(http://www.cdc.gov/ts/images/cdc/s.gif);"><a href="http://www.cdc.gov/">CDC Home</a></li>
            <li><a href="http://www.cdc.gov/about/">About CDC</a></li>
            <li><a href="http://www.cdc.gov/od/oc/media/">Press Room</a></li>
            <li><a href="http://www.cdc.gov/az/">A-Z Index</a></li>
            <li><a href="http://www.cdc.gov/contact/">Contact Us</a></li>
		</ul>
	</div>
<!-- End CDC Header Navigation Bar -->	
<!-- Start CDC Logo and Search Bar -->
	<div id="cdclogo">
		<a href="http://www.cdc.gov/" id="home">
	  <p>Department of Health and Human Services<br />Centers for Disease Control and Prevention</p></a>
	</div>
	<div id="cdcsearch">
		<form action="/search.do" method="get" name="searchForm" id="searchForm">
		<input type="hidden" value="search" name="action"/>
		<a href="http://www.cdc.gov/spanish/">CDC en Espa&ntilde;ol</a><br />
		<br />
		Search:
		<input maxlength="160" size="13" name="queryText" class="searchfield"/>
		<input name="image" type="image" src="http://www.cdc.gov/ts/images/cdc/btn_Go.gif" alt="Go" align="middle" class="gobtn" width="27" height="20" />
		</form>		
	</div>
<!-- End CDC Logo and Search Bar -->	
<!-- Start EID Banner -->
	<div id="eidlogo">
		<!-- header_starts_here //--><a href="http://www.cdc.gov/ncidod/eid" id="eidhome"><h1>Emerging Infectious Diseases</h1></a><!-- header_ends_here //-->
	</div>
	<div id="issn"><p>ISSN: 1080-6059</p></div>
<!-- End EID Banner -->	<!-- #EndLibraryItem --><div id="wrapper">
		<div id="articlecontent">
<!-- Start Right Column -->
			<div id="rcolarticle">
				<div id="hrblackdot"></div>
				<!-- #BeginLibraryItem "/Library/gblemailprint.lbi" --><ul id="email">
    				<li>
						<script type="text/javascript">
							var WindowObjectReference; // global variable
							function openRequestedPopup()
							{
							document.url = location.href
							WindowObjectReference = window.open("http://www2a.cdc.gov/ncidod/ts/emailthispage.asp?title=" + document.title + "&url=" + document.url + "&channel=EidNCID",
							"DescriptiveWindowName", "height=320,width=576,status=yes,toolbar=no,menubar=no,location=no,scrollbars= yes,resizable=yes");
							}
						</script>
						<a href="javascript://" onclick="openRequestedPopup();">Email this page</a>
					</li>
				</ul>
				<ul id="print">
					<li><a href="http://www2a.cdc.gov/ncidod/ts/print.asp">Printer-friendly version</a></li>
				</ul><!-- #EndLibraryItem --><!-- InstanceBeginEditable name="PDF Article" -->	
			  <ul id="pdf">
    				<li><a href="pdfs/617.pdf">Download this article as PDF</a></li>
   			  </ul>
<!-- InstanceEndEditable -->
<!-- Start EID Article Content Anchor Links -->
<!-- InstanceBeginEditable name="Article Content Anchor Links" -->
				<div id="rblock">
					<div id="hrblackdot"></div>
					<h4>Article Contents</h4>
					<ul id="rblocknav">
					  <li><a href="#stu">The Study</a></li>
						<li><a href="#con">Conclusions</a></li>
						<li><a href="#ack">Acknowledgments</a></li>
						<li><a href="#ref">References</a></li>
						<li><a href="javascript://" onclick="MM_openBrWindow('617-G.htm','','scrollbars=yes,resizable=yes,width=700,height=500')">Figure</a></li>
						<li><a href="javascript://" onclick="MM_openBrWindow('617-T.htm','','scrollbars=yes,resizable=yes,width=700,height=500')">Table</a></li>
						<li><a href="#cit">Suggested Citation</a></li>
					</ul>
				</div>		
<!-- InstanceEndEditable -->				
<!-- End EID Article Content Anchor Links -->
				<div id="hrblackdot"></div>			
			</div>	
<!-- End Right Column -->
<!-- InstanceBeginEditable name="Breadcrumbs" -->	
			<p id="breadcrumb"><a href="/ncidod/eid/index.htm">EID Journal Home</a> > <a href="contents_v13n04.htm">Volume 13, Number 4&ndash;April 2007</a></p>
<!-- InstanceEndEditable -->	
<!-- content_starts_here //-->
<!-- InstanceBeginEditable name="Article Content" -->
			<h4>Volume 13, Number 4&ndash;April 2007</h4>
			<h4><em>Dispatch</em></h4>
			<h1>Influenza Vaccine Effectiveness among US Military Basic Trainees, 2005&ndash;06 Season</h1>
			<p><strong>Jennifer K. Strickler,* <a href="#comment"><img src="../../../images/cdc/icon_email.gif" alt="Comments to Author" width="12" height="9" border="0" /></a> Anthony W. Hawksworth,* Christopher Myers,* Marina Irvine,*
  Margaret A.K. Ryan,* and Kevin L. Russell*</strong><br />
	  *Naval Health Research Center, San Diego, California, USA</p>
			<p><a href="#cit">Suggested citation for this article</a></p>
			<div id="abstract">
			  <p><strong>Abstract</strong><br />
			    Virtually all US military basic trainees receive
  seasonal influenza vaccine. Surveillance data collected from December 2005
  through March 2006 were evaluated to estimate effectiveness of the influenza
  vaccine at 6 US military basic training centers. Vaccine effectiveness against laboratory-confirmed
influenza was 92% (95% confidence interval 85%&ndash;96%).</p>
			</div>
			<p>Public health concerns over the potential for a devastating
    influenza pandemic in the near future are well known. Surveillance efforts have
    increased throughout the world, and much time and money have been directed
    toward preparedness for such a pandemic. Given that vaccination rates vary
    greatly among the nonmilitary population and that influenza diagnostics are
    sporadically available, annual influenza vaccine effectiveness studies based on
    laboratory-confirmed diagnoses are rare. However, evidence of locally
    circulating strains evading the vaccine-induced protection could be critical
    for early recognition and intervention. In addition, the emergence of pandemic
    strains within military populations has been noted. The first documented
    influenza outbreak in the spring of 1918, before the great influenza pandemic
    of 1918&ndash;19, was among recruits at Fort Riley, Kansas (<em><a href="#1">1</a></em>). In 1976, a unique strain of influenza (H1N1)
    caused an outbreak at Fort Dix, New Jersey, causing 1 death, and
    creating concern over spread of this nonvaccine strain (<em><a href="#1">2</a></em>). Highly vaccinated military
    populations, under close surveillance, provide the opportunity for annual
    calculation of influenza vaccine effectiveness, thereby benefiting global
  pandemic preparedness.</p>
			<h3><a name="stu" id="stu"></a>The Study</h3>
			<p>The Naval Health Research Center (NHRC) began conducting
			  tri-service surveillance for febrile respiratory illness at military
			  training centers in 1996; by 1999, this surveillance network had expanded to
			  include 8 of the largest military basic training centers in the United States (<em><a href="#1">3</a></em>). This surveillance includes the systematic
			  collection of throat swab specimens and clinical data (including but not
			  limited to gender, date of birth, symptoms, influenza vaccination status, type
			  of vaccine received, and date of vaccination) from consenting US military
			  trainees meeting the case definition for febrile respiratory illness (oral
			  temperature <u>&gt;</u>100.5&deg;F [38.0&deg;C] and a cough or sore throat). Samples
			  are stored locally at each site at -70&deg;C
			  until they are forwarded to the Naval Respiratory Disease Laboratory at NHRC
			  for viral culture and molecular diagnostic processing. Research personnel at
			  participating surveillance sites report the weekly number of trainees who
			  sought care for febrile respiratory illness and total trainee populations for
			  their respective sites, and rates for such illnesses are calculated.</p>
			<p>During the 2003&ndash;04 influenza season,
			  we recognized the opportunity of using data from this ongoing active
			  surveillance to estimate influenza vaccine effectiveness in protecting against
			  both laboratory-confirmed influenza and febrile respiratory illness of any
			  cause among US military basic trainees. Despite concerns that vaccine
			  effectiveness during the 2003&ndash;04 season would be low
			  because of the poor match between the components of the vaccine and the
			  circulating strain (<em><a href="#1">4</a></em>), the vaccine provided
			  good protection (94.4%) against laboratory-confirmed influenza that season (<em><a href="#1">5</a></em>). Annual vaccine effectiveness calculations are
			  important as we heighten our preparedness for pandemic influenza strains;
			  therefore, we performed similar calculations for the 2004&ndash;05 and 2005&ndash;06
			  seasons.</p>
			<p>During the late fall and winter seasons, all active-duty
			  military forces are required to receive the influenza vaccine, and this policy
			  is strictly enforced in training camps. Upon arrival, all incoming trainees
			  receive mandatory influenza vaccination, either the trivalent inactivated
			  influenza vaccine by injection (FluZone, Sanofi Pasteur, Lyon, France) or intranasal
			  cold-adapted, live, attenuated influenza vaccine (CA-LAIV) spray (FluMist, MedImmune, Gaithersburg,
			  MD, USA).</p>
			<p>For this analysis, vaccine protection was assumed to begin
			  14 days postvaccination. Therefore, in an 8-week
			  training program, 25% of trainees were considered &quot;unvaccinated&quot; at any given
			  time, assuming immunity takes 14 days to develop. Likewise, 33% of trainees in
			  a 6-week training program were considered unprotected by the vaccine at any time.
			  These assumptions allow estimates of denominator data for &quot;vaccinated&quot; and
			  &quot;unvaccinated&quot; person-weeks in calculations of vaccine effectiveness.</p>
			<p>From January through March 2006 all new trainees arriving
			  for basic training received the influenza vaccine; all recruits already present
			  had been vaccinated. The observation period for this analysis included January
			  1&ndash;March 31, 2006. However, 2 sites, Naval Service Training Command, Great
			  Lakes, and Marine Corps Recruit Depot, San Diego, had completed vaccination by December 2005.
			  Therefore, December was included in the observation period for those sites as
			  well. Total person-weeks in recruit training during the observation period were
			  obtained directly from the participating training centers. Vaccine effectiveness
			  was calculated for both laboratory-confirmed influenza and any cause of febrile
			  respiratory illness as follows: 100 &times; (1 &ndash; relative risk = 1 &ndash; [rate in vaccinated group]/[rate
			  in unvaccinated group]).</p>
			<p>During the observation period, 6 of 8 surveillance sites had
			  influenza activity and were included in this analysis. In 479,181 person-weeks
			  of observation, 4,052 cases of febrile respiratory illness were reported from
			  these 6 sites, and 722 patients were enrolled into the surveillance study
			  (includes throat swab specimen, case data, and consent). Seventy (9.7%)
			  specimens tested positive for influenza, by either culture or molecular
			  techniques.</p>
			<table width="150" border="0" align="right" cellpadding="5" cellspacing="0">
              <tr>
                <td bgcolor="#D8ECEB"><div align="center"><strong><a name="figure" id="figure"></a>Figure</strong></div></td>
              </tr>
              <tr>
                <td bgcolor="#D8ECEB"><img src="images/06-1308_t.gif" alt="Figure." width="150" height="100" /></td>
              </tr>
              <tr>
                <td bgcolor="#D8ECEB"><p class="txt-caption"><a href="javascript://" onclick="MM_openBrWindow('617-G.htm','','scrollbars=yes,resizable=yes,width=700,height=500')"><strong>Figure.</strong></a> Incidence of laboratory-confirmed influenza by
    vaccination status. AFB, Air Force Base; NSTC, Naval Service Training Command;
  MCRD, Marine Corps Recruit Depot.</p></td>
              </tr>
            </table>
			<p>Rates of laboratory-confirmed influenza were higher among
			  unvaccinated trainees at all sites except Fort Benning, Georgia,
			  which had only 3 cases (<a href="#figure">Figure</a>).
			  Overall, influenza vaccine effectiveness among US military trainees was 92%
			  (confidence interval [CI] 85.4&ndash;95.6%) during the 2005&ndash;06 season (<a href="javascript://" onclick="MM_openBrWindow('617-T.htm','','scrollbars=yes,resizable=yes,width=700,height=500')">Table</a>). Vaccine effectiveness against
			  laboratory-confirmed influenza was high (range 86%&ndash;94%) in each of the past 3
			  seasons. Vaccine effectiveness against non&ndash;laboratory-confirmed febrile
			  respiratory illness was lower, ranging from -10%
			  in 2005&ndash;06 to 52% in 2004&ndash;05.</p>
			<h3><a name="con" id="con"></a>Conclusions</h3>
			<p>This analysis suggests that the 2005&ndash;06 influenza vaccine
			  was highly effective in protecting US military basic trainees against
			  laboratory-confirmed influenza. Furthermore, these data suggest that both the
			  trivalent inactivated vaccine injection and the CA-LAIV intranasal spray were
			  equally effective, because the Marine Corps Recruit Depot in San Diego
			  vaccinated its trainees with CA-LAIV almost exclusively, and vaccine
			  effectiveness at that site was 95% (vaccine effectiveness at all other sites
			  combined = 90%).</p>
			<p>These estimates of effectiveness were supported by results
			  of additional analyses that would be expected to bias the outcome toward the
			  null hypothesis. For example, a 7-day lag period before immune response was
			  considered in an alternative analysis, and it yielded similar results: the
			  calculated vaccine effectiveness changed only slightly, from 92% to 90%. We
			  also analyzed vaccine effectiveness, assuming that 10% fewer trainees were
			  vaccinated at any given point, yet the calculated vaccine effectiveness was
			  only reduced to 87%.</p>
			<p>In contrast to the consistently high effectiveness of the
			  vaccines against laboratory-confirmed influenza, the effectiveness against
			  febrile respiratory illness of any cause was much lower and varied with each
			  season (13.9% in 2003&ndash;04, 52.1% in 2004&ndash;05, and -10%
			  in 2005&ndash;06). This lower effectiveness in 2005&ndash;06 is most likely due to
			  the generally high proportion of adenovirus infection seen in this population (<em><a href="#1">6</a></em>), and the lesser effectiveness is further
			  exacerbated by the tendency for adenoviral infections to occur beyond the
			  second week of training. The lower vaccine effectiveness seen against febrile
			  respiratory illness of any cause gives credence to the estimates of high
			  vaccine effectiveness against laboratory-confirmed influenza. If a measurement
			  bias existed, both estimates would be affected.</p>
			<p>As a highly vaccinated population, military personnel, and
			  basic trainees in particular, can provide critical information regarding the
			  effectiveness of each year's influenza vaccine formulations. Because of the
			  annual variations of both the vaccine formulations and the circulating strains,
			  influenza vaccine effectiveness should be evaluated annually. With the
			  ever-rising concerns of an imminent influenza pandemic, reliable and rigorous
			  influenza surveillance is paramount. Our existing surveillance network will
			  allow us to repeat the methods used in this analysis each year, thus providing
			  valuable estimates of influenza vaccine effectiveness to the public health
			  community.</p>
			<h4><a name="ack" id="ack"></a>Acknowledgments</h4>
			<blockquote>
              <p>Contributions from the following persons are gratefully
                acknowledged: Viola Paulk, Laura Pacha,
                Sharon Cole-Wainwright, Johnnie Conolly, R.J. Newsom,
                Robert Greenup, Susan Wolf, Shelly Oates, Mimms Mabee, John Gomez, Patricia Rohrbeck,
                Lorie Brosch, Edgar Tuliao,
                Josephine Genese, Annie Wang, Richard Skinner, staff
                from the Naval Respiratory Disease Laboratory, Naval Health Research Center;
                the Department of Defense Global Emerging Infection Surveillance and Response
                System; and the Henry M. Jackson Foundation for the Advancement of Military
                Medicine. Finally, we thank Gregory Gray for his original leadership regarding recruit
                respiratory infection surveillance.</p>
			  <p>Ms Strickler has coordinated
			    epidemiologic studies for the Department of Defense Center for Deployment
			    Health Research at Naval Health Research Center since 2000. Her
			    research interests focus on respiratory illness among military populations.</p>
	  </blockquote>
			<h4><a name="ref" id="ref"></a>References</h4>
			<ol>
			  <li><a name="1" id="1"></a>Swift W, Swift G. Influenza and influenzal pneumonia at Fort Riley, Kansas. JAMA. 1919;72:487&ndash;93.</li>
			  <li>Gaydos JC, Top FH Jr, Hodder RA, Russell PK. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16494712&amp;dopt=Abstract" target="_blank">Swine
			    influenza A outbreak, Fort Dix, New Jersey, 1976.</a> Emerg Infect Dis. 2006;12:23&ndash;8.</li>
			  <li>Ryan M, Gray G, Hawksworth A, Malasig M, Hudspeth M, Poddar S.
			    <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10920635&amp;dopt=Abstract" target="_blank">The Naval Health Research Center Respiratory Disease Laboratory.</a> Mil Med. 2000;165(Suppl 2):32&ndash;4.</li>
			  <li>Centers for Disease Control and
			    Prevention. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=14724559&amp;dopt=Abstract" target="_blank">Preliminary assessment of the effectiveness of the 2003&ndash;2004
			    inactivated influenza vaccine&mdash;Colorado,
			    December 2003.</a> MMWR. Morb Mortal Wkly Rep. 2004;53:8&ndash;11.</li>
			  <li>Russell KL, Ryan MAK, Hawksworth AW, Freed NE, Irvine
			    M, Daum LT; NHRC Respiratory Disease Surveillance
			    Team. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15734071&amp;dopt=Abstract" target="_blank">Effectiveness of the 2003&ndash;04 influenza vaccine among US military
			    basic trainees: a year of suboptimal match between vaccine and circulating
			    strain.</a> Vaccine. 2005;23:1981&ndash;5.</li>
			  <li>Russell KL, Hawksworth AW, Ryan MAK, Strickler J, Irvine M, Hansen CG, et
			    al. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16480793&amp;dopt=Abstract" target="_blank">Vaccine-preventable adenoviral respiratory illness in US military
			    recruits, 1999&ndash;2004.</a> Vaccine. 2006;24:2835&ndash;42.</li>
	  </ol>
			<h3>Figure</h3>
			<p><a href="javascript://" onclick="MM_openBrWindow('617-G.htm','','scrollbars=yes,resizable=yes,width=700,height=500')"><strong>Figure.</strong> Incidence of laboratory-confirmed influenza by
    vaccination status. AFB, Air Force Base; NSTC, Naval Service Training Command;
  MCRD, Marine Corps Recruit Depot.</a></p>
			<h3>Table</h3>
			<p><a href="javascript://" onclick="MM_openBrWindow('617-T.htm','','scrollbars=yes,resizable=yes,width=700,height=500')"><strong>Table.</strong> Vaccine effectiveness against laboratory-confirmed influenza among US military basic trainees, 2005&ndash;06</a></p>			
			<h3><a name="cit" id="cit"></a>Suggested Citation for this Article</h3>
			<p>Strickler JK, Hawksworth AW, Myers C, Irvine M, Ryan MAK, Russell KL. Influenza
    vaccine effectiveness among US military basic trainees, 2005&ndash;06 season. Emerg Infect Dis [serial on the
    Internet]. 2007 Apr [<em>date cited</em>]. Available
  from http://www.cdc.gov/EID/content/13/4/617.htm</p>
			<p><a name="comment" id="comment"></a>
	        </p>
			<div id="commenthdr">Comments to the Authors</div>	
			<div id="commentcontent">
				<p>Please use the form below to submit correspondence to the authors or contact them at the following address:</p>
				<p>Jennifer K. Strickler, Naval Health Research Center, PO Box 85122, San
Diego, CA 92186-5122, USA; email: <a href="mailto:strickler@nhrc.navy.mil">strickler@nhrc.navy.mil</a></p>
				<p><strong>Please note:</strong> To prevent email errors, please use no web addresses, email addresses, HTML code, or the characters <, >, and @ in the body of your message.</p>	<form action="http://www2a.cdc.gov/ncidod/eid/thankyou.asp" method="post" name="form1" onSubmit= "return validation(this)">
				<input type="hidden" name="RCPT" value="Strickler@nhrc.navy.mil" />
				<input type="hidden" name="Subject" value="Your article in the EID Journal" />
				<p><textarea name="textarea" cols="69" rows="10"></textarea></p>
				<p>Return email address:<br />
				<label><input name="From" type="text" size="45" /></label>
				</p>
				<p>
				<label><input type="submit" name="Submit" value="Submit" /></label>
				<label><input type="reset" name="Submit2" value="Reset" /></label>
				</p>
				</form>
			</div>
			<div id="commenthdr">Comments to the EID Editors</div>
			<div id="commentcontent">
				<p>Please contact the EID Editors at <a href="mailto:eideditor@cdc.gov">eideditor@cdc.gov</a></p>
			</div>														
<!-- InstanceEndEditable -->
<!-- InstanceBeginEditable name="Disclaimer" -->			
			<p id="datestamp">The opinions expressed by authors contributing to this  journal do not necessarily reflect the opinions of the U.S. Department of Health  and Human Services, the Public Health Service, the Centers for Disease Control and  Prevention, or the authors' affiliated institutions. Use of trade names is for  identification only and does not imply endorsement by any of the groups named  above.</p>
<!-- InstanceEndEditable -->	
<!-- InstanceBeginEditable name="Date Stamp" -->			
			<p id="datestamp">This page posted March 19, 2007<br />
This page last reviewed March 22, 2007</p>
<!-- InstanceEndEditable -->	
<!-- content_ends_here //-->
		</div>
  </div>	
<!-- Start Left Hand Nav -->
	<div id="lcol">		
			<div id="topicnav-wrapper"><!-- #BeginLibraryItem "/Library/gblleftnav.lbi" -->				<div id="topicnavhdr"><h4>Journal Contents</h4></div>
					<ul id="topicnav">
						<li><a href="/ncidod/eid/index.htm" id="journalhome">Home</a></li>
						<li><a href="/ncidod/eid/index.htm" id="expedited">Expedited</a></li>	
						<li><a href="/ncidod/eid/index.htm" id="current">Current Issue</a></li>	
						<li><a href="/ncidod/eid/upcoming.htm" id="aheadofprint">Ahead of Print</a></li>
						<li><a href="/ncidod/eid/pastcon.htm" id="past">Past Issues</a></li>
						<li><a href="/ncidod/eid/announc.htm" id="announcements">Announcements</a></li>																			
					</ul>	
				<div id="topicnavhdr"><h4>General Information</h4></div>	
						<ul id="topicnav">
						<li><a href="/ncidod/eid/about/about.htm" id="journalhome">About Us</a></li>
						<li><a href="/ncidod/eid/instruct.htm" id="expedited">Instructions to Authors</a></li>	
						<li><a href="http://mc.manuscriptcentral.com/eid/" id="current" target="_blank">Submit Manuscript</a></li>	
						<li><a href="/ncidod/eid/subscrib.htm" id="aheadofprint">Subscribe</a></li>
						<li><a href="/ncidod/eid/feedback.htm" id="past">Contact Us</a></li>																	
					</ul><!-- #EndLibraryItem --></div>		
  </div>		
<!-- End Left Hand Nav --><!-- #BeginLibraryItem "/Library/gblfooter.lbi" --><!-- Start Footer -->
	<div id="cdcftrnav">
		<ul>
			<li style="background-image: url(http://www.cdc.gov/ts/images/cdc/s.gif);"><a href="http://www.cdc.gov/">Home</a></li>
			<li><a href="http://www.cdc.gov/Other/policies.html">Policies and Regulations</a></li>
			<li><a href="http://www.cdc.gov/Other/disclaimer.html">Disclaimer</a></li>
			<li><a href="http://www.cdc.gov/Other/egovernment.html">e-Government</a></li>
			<li><a href="http://www.cdc.gov/od/foia/index.htm">FOIA</a></li>
			<li><a href="http://www.cdc.gov/contact/">Contact Us</a></li>
		</ul>
	</div>
	<div id="cdcftr">
		<div id="cdcftr-wrapper">
			<div id="cdcftrmcol">
				<div id="firstgov"><a href="http://www.usa.gov/"><span>USAGov -- The U.S. Government's Official Web Portal</span></a></div>
			</div>
			<div id="cdcftrrcol">
				<div id="cdcftrrcol-wrapper">
					<div id="cdcftrrcoll">
						<div id="dhhs"><a href="http://www.hhs.gov/"><span> </span></a></div>
					</div>
					<div id="cdcftrrcolr">
						<p><a href="http://www.hhs.gov/">Department of Health and Human Services</a></p>
					</div>
				</div>
			</div>
		</div>
		<div id="cdcftrlcol">
			<span>Safer Healthier People</span><p>Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A<br />Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435</p>
		</div></div>
<!-- End Footer -->	<!-- #EndLibraryItem --></div>
<!-- #BeginLibraryItem "/Library/gblomniture.lbi" --><div id="omniture">
	<!-- ####################################  -->
	<!-- BEGIN SiteCatalyst/Omniture code here-->
	<!-- Version 1.2: Date Created: 08/04/2004-->
	<script language="JavaScript" type="text/javascript">
	<!--
	var s_pageName=document.title
	var s_channel='EidNCID'<!-- end_channel //-->
	var s_code=' '//-->
	</script>
	<script language="JavaScript" src="/JScript/s_code.js" type="text/javascript"></script>
	<script language="JavaScript" type="text/javascript">
	<!--
	var s_wd=window,s_tm=new Date;if(s_code!=' '){s_code=s_dc('cdcgov');if(s_code)document.write(s_code)}else
	document.write('<im'+'g src="http://mtrics.cdc.gov/b/ss/cdcgov/1/G.5--FB/s'+s_tm.getTime()+'?[AQB]' +'&j=1.0&[AQE]" height="1" width="1" border="0" alt="" />')
	//-->
	</script>
	<script language="JavaScript" type="text/javascript">
	<!--
	if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-')
	//-->
	</script>
	<noscript>
	<img src="http://mtrics.cdc.gov/b/ss/cdcgov/1/G.5--NS/0?cl=Session" height="1" width="1" border="0" alt="" />
	</noscript>
	<!--/DO NOT REMOVE/-->
	<!-- END SiteCatalyst/Omniture code here-->
	<!-- ####################################  -->
</div><!-- #EndLibraryItem --></body>
<!-- InstanceEnd --></html>
